Education
About Us
Working with TipRanks
Follow Us
NeuroPace (NPCE)
NASDAQ:NPCE
Total Valuation
NeuroPace has a market cap or net worth of $272.92M. The enterprise value is $375.47M.
Market Cap$272.92M
Enterprise Value$375.47M
Share Statistics
NeuroPace has 33,081,497 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,081,497
Owned by Insiders27.52%
Owned by Institutions0.52%
Financial Efficiency
NeuroPace’s return on equity (ROE) is -3.39 and return on invested capital (ROIC) is -26.04%.
Return on Equity (ROE)-3.39
Return on Assets (ROA)-0.29
Return on Invested Capital (ROIC)-26.04%
Return on Capital Employed (ROCE)-0.27
Revenue Per Employee434.27K
Profits Per Employee-147.51K
Employee Count184
Asset Turnover0.84
Inventory Turnover1.56
Valuation Ratios
The current PE Ratio of NeuroPace is ―. NeuroPace’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value40.67
Price to FCF―
Price to Operating Cash Flow-19.04
PEG Ratio―
Income Statement
In the last 12 months, NeuroPace had revenue of 79.91M and earned -27.14M in profits. Earnings per share was -0.93.
Revenue79.91M
Gross Profit59.09M
Operating Income-21.67M
Pretax Income-27.14M
Net Income-27.14M
EBITDA-16.57M
Earnings Per Share (EPS)-0.93
Cash Flow
In the last 12 months, operating cash flow was -16.09M and capital expenditures -176.00K, giving a free cash flow of -16.23M billion.
Operating Cash Flow-16.09M
Free Cash Flow-16.23M
Free Cash Flow per Share-0.49
Dividends & Yields
NeuroPace pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.95
52-Week Price Change9.34%
50-Day Moving Average9.66
200-Day Moving Average11.38
Relative Strength Index (RSI)41.24
Average Volume (3m)212.01K
Important Dates
NeuroPace upcoming earnings date is Nov 11, 2025, After Close (Confirmed).
Last Earnings DateAug 12, 2025
Next Earnings DateNov 11, 2025
Ex-Dividend Date―
Financial Position
NeuroPace as a current ratio of 5.37, with Debt / Equity ratio of 367.93%
Current Ratio5.37
Quick Ratio4.48
Debt to Market Cap0.19
Net Debt to EBITDA-3.61
Interest Coverage Ratio-2.46
Taxes
In the past 12 months, NeuroPace has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NeuroPace EV to EBITDA ratio is -23.28, with an EV/FCF ratio of -21.14.
EV to Sales4.83
EV to EBITDA-23.28
EV to Free Cash Flow-21.14
EV to Operating Cash Flow-21.50
Balance Sheet
NeuroPace has $62.14M in cash and marketable securities with $71.52M in debt, giving a net cash position of $9.38M billion.
Cash & Marketable Securities$62.14M
Total Debt$71.52M
Net Cash$9.38M
Net Cash Per Share$0.28
Tangible Book Value Per Share$0.28
Margins
Gross margin is 75.74%, with operating margin of -27.12%, and net profit margin of -33.97%.
Gross Margin75.74%
Operating Margin-27.12%
Pretax Margin-33.97%
Net Profit Margin-33.97%
EBITDA Margin-20.74%
EBIT Margin-22.96%
Analyst Forecast
The average price target for NeuroPace is $16.86, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$16.86
Price Target Upside94.69% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast23.32%
EPS Growth Forecast23.29%